Tisch MS News

The Tisch MS Research Center has had twelve scientific research presentations accepted to the 66th annual meeting of the American Academy of Neurology. The conference is the largest gathering of the neurological community in the world and will take place at the end of April in Philadelphia. Twelve presentations marks a record for the center. Details of the research projects will be made available in the coming months on our websites.
The Tisch MSRCNY Phase I Clinical Stem Cell Trial was featured on the CBS Evening News on Monday, January 20th.  For those of you who missed the segment, CBS has posted the video and a text article on the study and its approval.  Please share the link with all of your family and friends. http://www.cbsnews.com/news/ms-patient-to-take-part-in-pioneering-experiment/
The Multiple Sclerosis Discovery Forum features a new article on the work of Dr. Massimiliano Cristofanilli and his team at the Tisch MS Research Center of New York in developing the first animal model of progressive MS:
For those of you who missed the original broadcast, Dr. Sadiq's segment on The Dr. Oz show is available on The Dr. Oz Show website: here (part 1) and here (part 2).
For those of you who missed the original broadcast, Dr. Sadiq's segment on The Dr. Oz show is available on The Dr. Oz Show website: here (part 1) and here (part 2).
Tune in to The Dr. Oz Show this Thursday, December 12th to see Dr. Sadiq as a featured guest along with his patient Richard Cohen and Richard's spouse Meredith Vieira. Richard and Meredith will be discussing living with MS and their hopes for our recently approved FDA Phase I Stem Cell Clinical Trial!
Dr. Steven A. Goldman, MD, PhD, Co-Director of the Center for Translational Medicine and Professor in the Departments of Neurology and Neurosurgery at the University of Rochester School of Medicine and Dentistry, delivered the Grand Rounds lecture for December 4, 2013. Dr. Goldman's presentation was entitled "Progenitor Cell-Based Therapy for Secondary Progressive Multiple Sclerosis."
Tisch MS Research Center of New York would like to advise patients and other interested parties that we will be closing at 2pm on Wednesday, November 27, and reopening on Monday, December 2, in observance of the Thanksgiving holiday.
Tisch MSRCNY welcomed almost 1,000 guests on Sunday, October 13, 2013 to the New York Hilton.  We would like to thank our patients and supporters for making this a truly momentous event! The title of Dr. Sadiq’s talk, “What Does This Study Mean For Me?” signified an opportunity to answer many questions about our recent FDA Approval to begin a Phase I Clinical Stem Cell Trial using autologous stem cells.  First and foremost, if you would like to express interest in participation in this study, you must speak to your IMSMP neurologist.
Multiple Sclerosis Journal has selected the recent Tisch MS publication "Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis," co-authored by Violaine Harris, PhD, and Saud Sadiq, MD, among others, as its cover article for October 2013.

Pages

Subscribe to MSRCNY News